Vienna: Vienna, Austria, October 13, 2017 – APEIRON Biologics AG, a Viennese company focussed on cancer immunotherapy, appointed Peter Llewellyn-Davies as new Chief Financial Officer and Chief Business Offi ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.